Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women (Q46683006)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2008

Language	Label	Description	Also known as
English	Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women	scientific article published in April 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

apoptotic process

1 reference

based on heuristic

inferred from title

Irene Lambrinoudaki

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

author name string

G E Christodoulakos

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

M G Creatsa

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

E V Economou

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

Z Siasou

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

C P Panoulis

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

I Kalligerou

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

C Papadias

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

publication date

1 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

11

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

155-165

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

Menopause and heart disease. A review

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Differential expression of factors involved in fat metabolism with age and the menopause transition

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Effects of 17beta-oestradiol plus different doses of drospirenone on adipose tissue, adiponectin and atherogenic metabolites in postmenopausal women

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Resistin is an inflammatory marker of atherosclerosis in humans.

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

The potential role of resistin in atherogenesis.

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Cross-sectional associations of resistin, coronary heart disease, and insulin resistance

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Vessel wall apoptosis and atherosclerotic plaque instability.

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Estrogen receptor-mediated, nitric oxide-dependent modulation of the immunologic barrier function of the endothelium: regulation of fas ligand expression by estradiol

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Soluble Fas, a mediator of apoptosis, C-reactive protein, and coronary and extracoronary atherosclerosis. The Rotterdam Coronary Calcification Study

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Resistin mRNA levels are downregulated by estrogen in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Effect of postmenopause and hormone replacement therapy on serum adiponectin levels

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Plasma adiponectin levels in post-menopausal women receiving hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Serum adiponectin concentration and cardiovascular risk factors in climacteric women

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Effect of raloxifene, estrogen, and hormone replacement therapy on serum homocysteine levels in postmenopausal women

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Endothelial function and menopause: effects of raloxifene administration

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Effect of hormone therapy and raloxifene on serum VE-cadherin in postmenopausal women

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Effects of tibolone on human breast cancer cells and human vascular coronary cells

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Oxidized LDL activates fas-mediated endothelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Modulation of survival in osteoblasts from postmenopausal women

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Soluble Fas ligand and atherosclerosis in hypertensive patients

1 reference

https://api.crossref.org/works/10.1080%2F13697130801954484

21 January 2018

Identifiers

10.1080/13697130801954484

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18365858

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46683006&oldid=2125977161"